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Outcomes of 23- and 24-weeks gestation infants in Wellington, New
Zealand: A single centre experience
Abstract

Optimal perinatal care of infants born less than 24 weeks gestation remains contentious due to uncertainty
about the long-term neurodevelopment of resuscitated infants. Our aim was to determine the short-term
mortality and major morbidity outcomes from a cohort of inborn infants born at 23 and 24 weeks gestation
and to assess if these parameters differed significantly between infants born at 23 vs. 24 weeks gestation. We
report survival rates at 2-year follow-up of 22/38 (58%) at 23 weeks gestation and 36/60 (60%) at 24 weeks
gestation. Neuroanatomical injury at the time of discharge (IVH ≥ Grade 3 and/or PVL) occurred in in 3/23
(13%) and 1/40 (3%) of surviving 23 and 24 weeks gestation infants respectively. Rates of disability at 2 years
corrected postnatal age were not different between infants born at 23 and 24 weeks gestation. We show
evidence that with maximal perinatal care in a tertiary setting it is possible to achieve comparable rates of
survival free of significant neuroanatomical injury or severe disability at age 2 in infants born at 23-week and
24-weeks gestation.
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Outcomes of 23- and 24-weeks
gestation infants in Wellington,
New Zealand: A single centre
experience
Mary Judith Berry1,2, Maria Saito-Benz1,2, Clint Gray1, Rebecca Maree Dyson1,3, Paula
Dellabarca2, Stefan Ebmeier4, David Foley5, Dawn Elizabeth Elder1 & Vaughan Francis
Richardson2
Optimal perinatal care of infants born less than 24 weeks gestation remains contentious due to
uncertainty about the long-term neurodevelopment of resuscitated infants. Our aim was to determine
the short-term mortality and major morbidity outcomes from a cohort of inborn infants born at 23 and
24 weeks gestation and to assess if these parameters differed significantly between infants born at 23
vs. 24 weeks gestation. We report survival rates at 2-year follow-up of 22/38 (58%) at 23 weeks gestation
and 36/60 (60%) at 24 weeks gestation. Neuroanatomical injury at the time of discharge (IVH ≥ Grade
3 and/or PVL) occurred in in 3/23 (13%) and 1/40 (3%) of surviving 23 and 24 weeks gestation infants
respectively. Rates of disability at 2 years corrected postnatal age were not different between infants
born at 23 and 24 weeks gestation. We show evidence that with maximal perinatal care in a tertiary
setting it is possible to achieve comparable rates of survival free of significant neuroanatomical injury or
severe disability at age 2 in infants born at 23-week and 24-weeks gestation.
Advances in perinatal medicine have led to a dramatic improvement in overall survival rates for extremely preterm infants1–3. As technological capacity increases, the need to define the threshold of infant viability and agree
on the ethical boundaries of neonatal intensive care becomes more urgent4. Despite improved overall survival
rates the burden of neurocognitive morbidity associated with extreme prematurity remains high5–7. However,
outcomes in previously published cohort studies reflect heterogeneous patient groups combining in-born and
out-born infants and those pooled from several institutions where practice variation may influence outcomes1,7–9.
Additionally, most outcome data focus on neurodevelopmental morbidity which, whilst important, does not
necessarily reflect the overall wellbeing of the child.
It remains extremely difficult to accurately predict the clinical course of an individual infant born in the periviable period of 23 weeks gestation10,11. Clinicians are therefore faced with the dilemma as to whether it is ethical to
initiate or withhold resuscitation when the outcomes are so uncertain12. Professional advisory bodies13–17 recognise
this dilemma and recommend that discussion between health professionals and the infants’ family must underpin
any clinical decision to withhold or instigate resuscitation of the periviable infant18. Ideally this discussion should be
informed by clear short- and long-term morbidity and mortality data that is pertinent to the local tertiary institution.
In the current study we sought to address, in a population of 23 and 24 weeks gestation infants, rates of death and
major morbidity at time of discharge home, and rates of disability at 2 years corrected postnatal age. The secondary
aim was to assess whether the above parameters differed significantly between infants born at 23 or 24 weeks gestation.
We report our primary outcome of survival at 2 years corrected postnatal age free of moderate or severe
disability. Our secondary outcomes include 1: survival to (i) NICU admission, (ii) discharge home, (iii) 2 years
corrected postnatal age; 2: Maternal and neonatal wellbeing at the time of birth; 3: Major neonatal morbidity.
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Methods

Study population. Cases were identified from the birth registration of infants born between 23+0 and 24+6 weeks

of gestation in Wellington Regional Hospital, between 1st January 2003 and 31st December 2012. Cases were retrieved
from our institutional database and clinical details cross-checked against the paper clinical record. Gestational age was
defined by first trimester dating ultrasound, or by date of last menstrual period if no early ultrasound scan was available. Infants were excluded if out-born, the parents declined resuscitation, or significant congenital anomalies were
present. Seven infants were excluded due to congenital abnormalities including major cardiac and abdominal wall
anomalies. Resuscitation was not initiated in 11 infants due to wishes of parents in agreement with the medical team.
Key data were extracted including decisions to initiate or withhold newborn resuscitation, the infants’ medical course,
health status at the time of discharge home and during follow-up assessments at 2–3 years corrected postnatal age.

Maternal characteristics. Maternal age, ethnicity and health status were obtained from patient records.
Chorioamnionitis was determined by the attending obstetrician and confirmed following placental histology.
Prolonged rupture of membranes was defined as rupture of membranes >24 hrs before delivery. Pre-eclampsia
was defined by the obstetricians’ clinical interpretation of maternal symptoms, blood pressure, blood and urinary
tests. Incomplete course of steroid was defined as one dose of betamethasone given <12 hours prior to delivery.
Complete course of steroid was defined as two doses of betamethasone given 12 hours apart with the second dose
<7 days prior to delivery. Mode of delivery and its indication were obtained from the maternal delivery record.
Neonatal characteristics. Birth weight was measured in the NICU using a portable scale with accuracy of +/−2 grams (Tanita Corporation, Japan) or an in-built incubator scale with accuracy of +/−10 grams
(Giraffe OmniBed, GE Healthcare, UK). Birth weight centile was derived from the New Zealand – World Health
Organisation growth charts (Ministry of Health, New Zealand). Neonatal sepsis was defined by presence of a positive
blood, urine or CSF culture within 48 hours of sample collection. Presence of patent ductus arteriosus (PDA) was
determined by an echocardiogram performed within 24hrs of birth for all infants, and in this cohort prophylactic
indomethacin (ibuprofen was substituted briefly during the study period due to a national shortage of indomethacin) was given routinely if a PDA was present unless a contraindication was identified (e.g., significant thrombocytopaenia; gastrointestinal perforation or bleeding). Diagnosis of necrotising enterocolitis (NEC) was based on the
Bell classification and includes stages I to III. It is customary practice in our Unit to complete 7 days of intravenous
triple antibiotics (amoxycillin, gentamycin and metronidazole) and nil by mouth for infants with NEC (Bell stage
I-III). Therefore, all cases significant enough to warrant treatment have been included in subsequent analysis as a
measure of potentially serious gastrointestinal morbidity. Presence of intraventricular haemorrhage (IVH) and/or
periventricular leucomalacia (PVL) was determined by serial cranial ultrasonography performed and interpreted by
paediatric radiologists. Reported grade of IVH/PVL (Papile classification) reflects the most significant abnormality
found at any time during the infants’ admission. Diagnosis of bronchopulmonary dysplasia (BPD) was made if
supplementary oxygen was required at 28 days of life, and was defined as moderate if infants required <30% oxygen
at 36 weeks corrected postnatal age and severe if infants required >30% oxygen at 36 weeks corrected postnatal
age. Presence of retinopathy of prematurity (ROP) and need for laser therapy was determined by serial paediatric
ophthalmology examination commenced between 30 and 31 weeks corrected postnatal age. Of note, in our Unit,
administration of exogenous surfactant to infants born at 23 and 24 weeks gestation was universal practice; all infants
therefore received at least one dose in the newborn period. Similarly, administration of probiotics only commenced
in our Unit after 2013; none of the infants included in this cohort therefore received probiotic treatment.
Definitions of moderate to severe disabilities. Moderate to severe disabilities in this study are defined

broadly to reflect neurodevelopmental disability as well as respiratory, gastrointestinal and renal complications
of prematurity as per the ‘classification of health status at 2 years as a perinatal outcome’ published in 2008 by the
British Association of Perinatal Medicine and Royal College of Paediatrics and Child Health Working Group19.
This allows validated reporting of morbidity outcomes in children unable to access a standardised post-discharge
developmental surveillance program. Many of the children in this cohort were domiciled in rural communities
where follow-up is with a Paediatrician but may not include specialist neurodevelopmental assessment using
Bayley or Griffith neurodevelopmental scales. Health outcomes were obtained by review of clinical records at
2 years corrected postnatal age. All records were independently assessed by at least 2 paediatric-trained investigators and reconciled by a third senior, paediatric-trained investigator if necessary. Wellbeing was assessed in
domains of: neurodevelopmental (including motor, cognitive, hearing, speech & language, vision), respiratory,
renal and gastrointestinal. One or more impairment in any ‘severe disability’ domain was classified as the child
having severe disability. Similarly, one or more impairment in the ‘moderate’ disability domain was required for
classification as moderately disabled (Table 1).

Statistical analysis. Stata 13 for MacOSX (StataCorp LP, Texas, USA) was used for statistical analyses. χ2
analysis was used to compare outcomes between those born at 23 vs. 24 weeks gestation. Associations between
maternal characteristics and infant outcome were explored using multivariate regression analysis. The level of
statistical significance for all analyses was set at p ≤ 0.05 using two-tailed comparisons. Data are presented as the
mean ± SEM or median (range) as indicated in the text. Percentage survival rate was determined using the number of live born infants at each gestational age as the denominator for all outcomes.
Ethical approval. Institutional ethics approval to review the health records was prospectively obtained
from the Wellington Hospital Clinical Audit and Research Committee. All health records were anonymised and
de-identified prior to analysis. All methods and patient information were performed in accordance with the
relevant guidelines and regulations outlined by the Wellington Hospital Clinical Audit and Research Committee.
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Domain

Severe neurodevelopmental disability

Motor

CP with GMFCS ≥ 3

Moderate neurodevelopmental disability
CP with GMFCS 2

Cognitive

Score ≤−3SD below norm on formal testing Or
Paediatrician assessment of severe disability

Score between -3SD and -2SD below norm on formal testing Or
Paediatrician assessment of reduced cognitive function

Hearing

No useful hearing even with aids

Hearing loss corrected with aids

Speech &
language

No words

<5 words

Vision

No useful vision

Moderately reduced vision in both eyes, or unilateral blindness with
good vision in contralateral eye

Gastrointestinal

TPN, NG, or PEG requirement

Special diet or stoma

Renal

Dialysis or awaiting renal transplant

Renal impairment needing treatment or special diet

Table 1. Summary of wellbeing at 2 years corrected postnatal age. GMFCS: Gross motor function classification
scales. TPN: total parenteral nutrition. NG: nasogastric tube feeding. PEG: percutaneous entero-gastrostomy.

Results

116 infants were born at 23 and 24 weeks gestation from 102 mothers. Of 98 infants eligible for study inclusion, 38
were born at 23+0−6 gestation and 60 were born at 24+0−6 gestation. There were more males (n = 60) than females
(n = 38) (Fig. 1). 34/38 infants of the 23-week cohort and 59/60 infants of the 24-week cohort were admitted to
NICU (Fig. 1). Resuscitation was unsuccessful in four infants born at 23 weeks gestation (all male, all had received
a partial course of antenatal corticosteroid, median birth weight 600 g (560–780 g)) and one born at 24 weeks
gestation (male, birth weight of 500 g and had received a full course of antenatal corticosteroid).

Maternal characteristics.

Following exclusion of neonates according to the previously defined exclusion
criteria, 90 mothers were included in the analysis. There was no maternal difference between the 23-week and
24-week cohort in any perinatal variables (Table 2). For purposes of reporting perinatal outcomes, mothers of
twins are only included once, with the exception of three mothers (1 with twins born at 23 weeks, and 2 with twins
born at 24 weeks). As these mothers had one twin who survived, and one non-surviving twin, these mothers are
included in the final numbers for both “survivors” and “non-survivors”.

Post-admission Neonatal course. Twenty-three infants in the 23-week cohort (61%) and 40 infants in the

24-week cohort (67%) survived to discharge home (Fig. 1). Birth weight was not significantly different between 23
& 24-week infants. However, within the 24-week cohort, birth weight was significantly higher in survivors when
compared to non-survivors (median, range: 678, 535–880 vs. 630, 430–800, p = 0.05). Apgar score at 5 minutes
was significantly lower in 23-week infants when compared to 24-week infants (median, range: 7, 2–9 vs. 9, 3–10
p < 0.01) (Table 3). Culture positive sepsis (early & late) was common in both age cohorts. Of the survivors,
those born at 23-weeks required a longer total period of mechanical ventilation during the entire duration of
admission than those born at 24-weeks gestation (median, range: 28, 4–68 days vs. 14, 2–60 days, p = 0.002). No
difference in rates of NEC, ROP or any other medical or surgical complications were observed between or with
groups (Table 3). Indomethacin/ibuprofen to treat a PDA was given to most infants at 23 and 24 weeks gestation
(Table 3). Further surgical ligation of the PDA was required in four infants born at 23 weeks gestation of whom
two survived, and five infants born at 24 weeks gestation of whom two survived.

Morbidity at time of discharge.

There was no difference in age at discharge between infants discharged
directly from NICU or step-down level 2 units and there was no difference in major morbidity between those
born at 23- or 24-weeks gestation. ROP requiring laser treatment was seen in 4/23 infants (18%) in the 23-week
cohort and 6/40 infants (15%) in the 24-week cohort. 11/23 infants (48%) and 14/40 infants (35%) in the 23-week
cohort and 24-week cohort respectively were discharged home with supplementary low-flow oxygen. Twenty
out of 23 surviving 23-week gestation infants (87%) and 39/40 surviving 24-week gestation infants (97%) had no
major neuroanatomical abnormalities (IVH ≥ 3 or PVL) detected at any time during their clinical course.

Cause and timing of neonatal death. The majority of NICU deaths occurred within the first week
(Fig. 2). Of the 30 infants who died in NICU, active palliation was instituted in 19 (63%) (Supplementary Table 1).
Major morbidity preceding death in infants who were transitioned to palliative care included severe IVH/PVL
(n = 6), respiratory failure (n = 3), overwhelming sepsis (n = 1), or a combination of factors (n = 9). For those
infants who died whilst still receiving active neonatal care, sepsis and necrotising enterocolitis were the commonest causes of death (Supplementary Table 1).
Survival at 2 years corrected age.

Following discharge from the neonatal units, one 23 weeks gestation
infant and four 24 weeks gestation infants died before 2 years corrected age. Overall survival rates of liveborn
infants is therefore 58% (22/38) and 60% (36/60) in 23-week and 24-week cohorts respectively at 2 years corrected
postnatal age (Fig. 1).

Health and wellbeing amongst survivors at 2 years corrected age. Of the surviving children at
2 years corrected postnatal age for whom health status data were available (19/22, 86%, in the 23 week cohort;
31/36, 86%, in the 24 week cohort), 11/19 (58%) and 23/31 (74%) were free of any moderate or severe health
impairments, in the 23- and 24-week cohorts respectively (Table 4). Health status data were not available for three
SCIeNTIfIC Reports | 7: 12769 | DOI:10.1038/s41598-017-12911-5
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Figure 1. Overview of the study cohort. GA indicates gestational age. DS indicates delivery suite. All
percentages are calculated with the number of live births as the denominator.

in the 23-week cohort and five in the 24-week cohort, in two cases due to families moving overseas. As specialist
health care for children in New Zealand is publically funded, this suggests that the children lost to medical follow
up but domiciled in NZ are unlikely to have major health needs.

Discussion

In the current study, we have clearly demonstrated that where management of the periviable infant includes provision for active perinatal care with maternal delivery at a tertiary neonatal centre, survival free of significant
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Characteristic/Morbidity

23 weeks GA (n = 36)
Survivors (n = 57)

Maternal age (years)

Non-Survivors (n = 33)
Survivors (n = 57)

Multiple pregnancy

Non-Survivors (n = 33)
Survivors (n = 57)

Pre-eclampsia

Non-Survivors (n = 32)
Chorioamnionitis

Survivors (n = 47)

Non-Survivors (n = 27)
Rupture of membranes >24 h

Survivors (n = 56)

Non-Survivors (n = 33)
Antepartum haemorrhage

Survivors (n = 57)

Non-Survivors (n = 33)
Vaginal breech delivery†

Survivors (n = 26)

Non-Survivors (n = 21)
Caesarean section Delivery

Survivors (n = 57)

Non-Survivors (n = 33)
Lower segment caesarean section‡ Survivors (n = 31)
Non-Survivors (n = 12)
Fetal indication for operative delivery
(n = 31)
Non-Survivors (n = 12)
Maternal smoking Survivors (n = 52)
Non-Survivors (n = 30)

Survivors

24 weeks GA (n = 54)

30 (15–40)

31 (17–39)

30 (17–40)

33 (18–39)

4 (19%)

7 (19%)

1 (7%)

4 (22%)

3 (14%)

3 (8%)

0

5 (29%)

6 (40%)

17 (53%)

7 (58%)

7 (47%)

7 (33%)

12 (34%)

6 (40%)

5 (28%)

2 (10%)

6 (17%)

4 (27%)

1 (6%)

3 (23%)

6 (46%)

6 (55%)

3 (30%)

8 (38%)

22 (61%)

4 (27%)

8 (44%)

7 (88%)

21 (91%)

3 (75%)

6 (75%)

8 (100%)

20 (90%)

4 (100%)

5 (63%)

4 (20%)

14 (44%)

2 (14%)

4 (25%)

Table 2. Maternal characteristics of the study group. Data presented as median (range) for continuous variables
or n (%) for categorical variables. % listed is calculated from number of infants/mothers with information
available, not total participants (98 infants; 63 survivors, 35 non-survivors). †Calculated from vaginal deliveries
only (caesarean section deliveries excluded from count). ‡Lower segment caesarean rate calculated as a
proportion of the total caesarean rate.

disability at 2 years corrected postnatal age can be achieved. In addition, birth at 23 weeks gestation did not confer
any additional burden of surgical or medical complexity when compared to infants born at 24 weeks gestation, and
survival rates of infants born at 23 weeks gestation were comparable to those of infants born at 24 weeks gestation.
Birth at less than 24 weeks gestation remains uncommon, and consequently the ‘optimal’ perinatal care of
infants born prior to 24 weeks gestation remains unclear12,20–23. These complexities are reflected in the different
gestational age thresholds at which resuscitation and active care is initiated24,25. However, in New Zealand and
across the world, there is no formally agreed national consensus in practise, leading to variation between tertiary
institutions and their referring regional hospitals. Differences in local and international practice make comparisons between centres challenging. Many centres report widely different rates of antenatal corticosteroid use,
operative birth and other perinatal care strategies that may explain the variation in morbidity and mortality20,23,24.
Furthermore, early trimester dating scans have a margin of error that undermines treatment threshold decisions
based on gestational age alone26. Similarly, the effect of other variables, including corticosteroid exposure can
modify survival risk significantly11. Thus if an a priori decision has been made to withhold corticosteroids at 23
weeks, the infant will never have the benefit of ‘optimised’ care and outcomes will inevitably be less good than
they could be. Survival rates may be described relative to the total number of births, the number of infants live
born, or the number of infants admitted to the NICU27. We suggest for meaningful counselling of parents as well
as comparison between centres, survival is reported based on the number of liveborn babies, with those admitted
to NICU as well as discharged home reported to avoid any bias with either over or under-reporting.
In the current study, we report survival rates at 2 years corrected age of 58% and 60% amongst all live born infants
in the 23- and 24-week gestation cohorts. Our survival rates are comparable with the recently published Japanese and
Swedish data25,28 although we report lower rates of neurological injury in survivors than the Japanese cohort. In both
our cohort and the Swedish cohort, antenatal corticosteroid exposure and operative delivery rates were high. However,
in comparison to obstetric practice in Sweden, antenatal dating ultrasound scans in NZ are routine during the first
trimester when gestational age may be calculated with a greater degree of precision. Thus, it is possible that Swedish
cohorts may include relatively more mature but growth restricted infants29. It is also customary in our Unit when
infants have developed significant IVH and, or, PVL to discuss possible redirection of care from active intervention
to palliation and ‘comfort care’. The striking difference in rates of grade 3/4 IVH between survivors and non-survivors
therefore reflects our philosophy of open discussion with parents and wider family, ideally prior to birth, of possible
limitation of active care should complications with a significant risk of later neurodevelopmental morbidity develop.
In the current study, BPD and requirement for supplementary low-flow oxygen at discharge were common.
However, as lung development continues through childhood, we do not regard this as an indication to exclude
23-week gestation infants from active NICU care. More importantly, we have also shown that most infants discharged home did not have evidence of significant neurological injury (Grade 3/4 IVH: 3/23 (13%) in surviving
SCIeNTIfIC Reports | 7: 12769 | DOI:10.1038/s41598-017-12911-5
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Survivors (n = 63)

Birth weight (g)

Non- Survivors (n = 30)
Survivors (n = 63)

Birth weight <10th percentile

Non- Survivors (n = 30)
Survivors (n = 63)

Any antenatal corticosteroids

Non- Survivors (n = 30)
Completed antenatal corticosteroids

Survivors (n = 63)

Non- Survivors (n = 30)
Survivors (n = 63)

Cord pH

Non- Survivors (n = 30)
Survivors (n = 63)

Apgar score at 5 minutes

Non- Survivors (n = 30)
Survivors (n = 63)

Inotrope requirement

Non- Survivors (n = 30)
PDA treated with indomethacin/ibuprofen

Survivors (n = 63)

Non- Survivors (n = 30)
Proven systemic infection

Survivors (n = 63)

Non- Survivors (n = 30)
Necrotising enterocolitis (Bell’s I–III)

Survivors (n = 63)

Non- Survivors (n = 30)
Days on mechanical ventilation (total)
Non- Survivors (n = 30)
Home oxygen

Survivors (n = 63)
Non- Survivors (n = 30)

Moderate BPD

Survivors (n = 63)
Non- Survivors (n = 30)

Severe BPD
ROP ≥ Grade 3

p-value

678 (535–880)

0.03

630 (525–740)

630 (430–800)*

NS

3 (13%)

5 (13%)

NS

1 (9%)

6 (32%)

NS

20 (91%)

39 (100%)

NS

11 (100%)

18 (95%)

NS

12 (60%)

12 (67%)

NS

6 (55%)

15 (83%)

NS

7.3 (6.9–7.5)

7.4 (7.0–7.4)

NS

7.3 (6.8–7.4)

7.3 (7.1-7.4)

NS

7 (2–9)

9 (3–10)

0.009

8 (3–10)

9 (4–10)

NS

12 (52%)

18 (45%)

NS

7 (64%)

9 (53%)

NS

23 (100%)

33 (83%)

NS

10 (91%)

14 (78%)*

NS

20 (87%)

26 (65%)

NS

7 (64%)

7 (37%)*

NS

9 (39%)

12 (30%)

NS

3 (27%)

7 (54%)

NS

28 (4–68)

14 (2–60)

0.002

6 (1–85)

14 (1–62)

NS

11 (48%)

14 (36%)

NS

n/a

n/a

—

8 (35%)

15 (38%)

NS

n/a

n/a

—

Survivors (n = 63)

12 (52%)

17 (43%)

NS

n/a

n/a

—

Survivors (n = 63)
Survivors (n = 63)
Non- Survivors (n = 30)

PVL

24 weeks GA (n = 59)

635 (475–800)

Non- Survivors (n = 30)
Non- Survivors (n = 30)
IVH ≥ Grade 3

Survivors (n = 63)

23 weeks GA (n = 34)

Survivors (n = 63)
Non- Survivors (n = 30)

5 (22%)

7 (18%)

NS

0

2 (11%)

NS

1 (4%)

1 (3%)

NS

4 (36%)*

7 (37%)*

NS

2 (9%)

1 (3%)

NS

1 (9%)

1 (5%)

NS

Table 3. Characteristics and outcomes of infants admitted to NICU. Data presented as median (range) for
continuous variables or n (%) for categorical variables. % values calculated from total neonates with data
available for given variable. Total number of admission to NICU (93 infants; 63 survivors and 30 non-survivors
at time of discharge home). *Denotes significant difference (p < 0.05) between survivors and non-survivors
within gestational age. NS denotes non-significance.

23-week gestation infants and 1/40 (3%) in surviving 24-week gestation infants) and rates of moderate to severe
disability were comparable between those born at 23 and 24 weeks gestation at 2 years corrected age. A recently
published study suggests that a higher rate of survival without impairment in 23 weeks gestation infants is found
in those institutions with higher rate of active resuscitation for extremely preterm infants30. Our study supports
this finding as our high rate of resuscitation in 23 weeks gestation infants did not result in excess morbidity and
mortality compared to infants born at 24 weeks gestation.
Our study has a number of limitations that need to be acknowledged. This is a retrospective study where the data
derive from a single tertiary centre with materno-fetal medicine and neonatal expertise available on site. The type
of resource available to women and their babies is therefore not representative of the majority of birthing centres
where access to tertiary services will necessarily be delayed. Similarly, as we wished to describe outcomes where it
was perceived that maximal perinatal support was provided we did not include out-born infants requiring postnatal
retrieval to tertiary care as this is recognised to significantly increase the risk of morbidity and mortality. Outcomes
at 2 years corrected postnatal age are derived as a composite of formal developmental and, or, paediatric assessment.
While this is not as robust as a universal standardised health and developmental assessment, it does provide a valuable, holistic overview of the child’s wellbeing while reflecting the limitations of routine clinical follow-up.

Conclusion

We have shown survival free of moderate or severe disability can be achieved in infants born at 23 weeks gestation when
maximal perinatal care is provided in a publically-funded tertiary setting. We also report that, in the current study,
there were no clear perinatal factors that reliably predicted infant outcome. Importantly, our high rate of resuscitation
SCIeNTIfIC Reports | 7: 12769 | DOI:10.1038/s41598-017-12911-5
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Figure 2. Kaplan-Meier survival estimate curve. Day-by-day actuarial survival rate of periviable infants born at
the Wellington Hospital. Data is stratified by gestational age at birth: 23 weeks (solid line) and 24 weeks (dashed
line). Only those infants admitted to the neonatal intensive care unit are included. (A) Survival to 1-year
chronological age (B) Enhanced view of survival over first 30 days of life.
23 weeks GA (n = 19)*

24 weeks GA (n = 31)*

Moderate disability overall

4 (21%)

5 (16%)

Motor

3 (16%)

0

Cognitive

3(16%)

0

Hearing

1 (5%)

0

Speech and language

1 (5%)

4 (13%)

Vision

1 (5%)

2 (6%)

Respiratory

0

0

Gastrointestinal

0

1 (3%)

Renal

0

0

Severe disability overall

4 (21%)

3 (10%)

Motor

1 (5%)

0

Cognitive

3 (16%)

2 (6%)

Hearing

0

0

Speech and language

1 (5%)

1 (3%)

Vision

0

0

Respiratory

1 (5%)

0

Gastrointestinal

1(5%)

0

Renal

0

0

p-value

NS

NS

Table 4. Disability among survivors at 2 years corrected age. Overall diagnosis of moderate or severe disability
was given based on the most severe disability found. *Total numbers of survivors at 2 years of age for whom
complete medical records are available.

in infants born at 23 weeks did not result in a disproportionately high burden of severely neurologically compromised
infants. Furthermore, given that most death occurs in the first week after birth our practice of active intervention does
not have major adverse implications for resource management. We therefore recommend that dialogue in this area
should focus on improving equitable access of high-risk women to maximal perinatal care settings, rather than focus
on whether or not to withhold potentially lifesaving treatment in infants born before 24 weeks of gestation.
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